SCM
LJPC

Scopia Capital Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Scopia Capital Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-480,000
Closed -$3.09M – 31
2019
Q1 		$3.09M Sell
480,000
-1,907,336
-80% -$12.4M 0.11% 23
2018
Q4 		$22.5M Sell
2,387,336
-202,876
-8% -$3.05M 0.76% 22
2018
Q3 		$52.1M Buy
2,590,212
+7,042
+0.3% +$184K 1% 25
2018
Q2 		$75.4M Buy
2,583,170
+2,005,025
+347% +$61.9M 1.32% 27
2018
Q1 		$17.2M Buy
+578,145
New +$18.6M 0.34% 28

Other funds holding LJPC

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
VMI
VHCP Management III New York $504M AUM 683.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Scopia Capital Management's LJPC Position: Q2 2019 in Review

Scopia Capital Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2019, closing a stake of 480,000 shares — an estimated $3.09M sold.

Scopia Capital Management first reported a position in LJPC in Q1 2018 and held it in 5 quarters. The position peaked at $75.4M in Q2 2018. 80 funds tracked by Wall St. Rank hold LJPC as of Q2 2019.

  • Scopia Capital Management reported no remaining La Jolla Pharmaceutical Company position as of Q2 2019 after selling out during the quarter.
  • Scopia Capital Management sold 480,000 La Jolla Pharmaceutical Company shares in Q2 2019, an estimated $3.09M.
  • Scopia Capital Management first reported a position in La Jolla Pharmaceutical Company in Q1 2018 and held it in 5 quarters.
  • Scopia Capital Management's La Jolla Pharmaceutical Company position peaked at $75.4M in Q2 2018.
  • 80 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2019.

Based on Scopia Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.